Advertising Disclaimer »

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

From the American Academy of PediatricsTechnical Report

Food Additives and Child Health

Leonardo Trasande, Rachel M. Shaffer, Sheela Sathyanarayana and COUNCIL ON ENVIRONMENTAL HEALTH
Pediatrics August 2018, 142 (2) e20181410; DOI: https://doi.org/10.1542/peds.2018-1410
Download PDF

Abstract

Increasing scientific evidence suggests potential adverse effects on children’s health from synthetic chemicals used as food additives, both those deliberately added to food during processing (direct) and those used in materials that may contaminate food as part of packaging or manufacturing (indirect). Concern regarding food additives has increased in the past 2 decades in part because of studies that increasingly document endocrine disruption and other adverse health effects. In some cases, exposure to these chemicals is disproportionate among minority and low-income populations. This report focuses on those food additives with the strongest scientific evidence for concern. Further research is needed to study effects of exposure over various points in the life course, and toxicity testing must be advanced to be able to better identify health concerns prior to widespread population exposure. The accompanying policy statement describes approaches policy makers and pediatricians can take to prevent the disease and disability that are increasingly being identified in relation to chemicals used as food additives, among other uses.

  • Abbreviations:
    AAP —
    American Academy of Pediatrics
    AFC —
    artificial food color
    BPA —
    bisphenol A
    DEHP —
    di-2-ethylhexylphthalate
    DIDP —
    diisodecyl
    DINP —
    diisononylphthalate
    FDA —
    Food and Drug Administration
    GRAS —
    generally recognized as safe
    NIS —
    sodium iodide symporter
    NOC —
    N-nitroso compound
    PFC —
    perfluoroalkyl chemical
    PFHxS —
    perfluorohexane sulfonic acid
    PFNA —
    perfluorononanoic acid
    PFOA —
    perfluorooctanoic acid
    PFOS —
    perfluorooctane sulfonic acid
    NHANES —
    National Health and Nutrition Examination Survey

    • More than 10 000 chemicals are allowed to be added to food in the United States, either directly or indirectly, under the 1958 Food Additives Amendment to the 1938 Federal Food Drug and Cosmetic Act (Public Law 85-929). An estimated 1000 chemicals are used under a “Generally Recognized as Safe” (GRAS) designation without US Food and Drug Administration (FDA) approval or notification.1 Many chemical uses have been designated as GRAS by company employees or hired consultants.2 Because of the overuse of the GRAS process and other key failings within the food safety system, there are substantial gaps in data about potential health effects of food additives. Of the 3941 food additives listed on the “Everything Added to Food in the United States” Web site, reproductive toxicology data were available for only 263 (6.7%), and developmental toxicology data were available for only 2.3

    Accumulating evidence from nonhuman laboratory and human epidemiologic studies suggests that colorings, flavorings, chemicals deliberately added to food during processing (direct food additives), and substances in food contact materials (including adhesives, dyes, coatings, paper, paperboard, plastic, and other polymers) that may come into contact with food as part of packaging or processing equipment but are not intended to be added directly to food (indirect food additives) may contribute to disease and disability in the population (Table 1). Children may be particularly susceptible to the effects of these compounds because they have higher relative exposures compared with adults (because of greater dietary intake per pound), their metabolic (ie, detoxification) systems are still developing, and key organ systems are undergoing substantial changes and maturations that are vulnerable to disruptions.4 Chemicals of increasing concern include bisphenols, which are used in the lining of metal cans to prevent corrosion5; phthalates, which are esters of diphthalic acid that are used in adhesives and plasticizers during the manufacturing process6; nonpersistent pesticides, which have been addressed in a previous American Academy of Pediatrics (AAP) policy statement and thus are not discussed in this report7; perfluoroalkyl chemicals (PFCs), which are used in grease-proof paper and paperboard food packaging8; and perchlorate, an antistatic agent used for packaging in contact with dry foods with surfaces that do not contain free fat or oil.9 Nitrates and nitrites, which have been the subject of previous international reviews,10 and artificial food coloring also are addressed in this report.

    View this table:
    TABLE 1

    Summary of Food-Related Uses and Health Concerns for the Compounds Discussed in This Report

    This technical report will not address other contaminants that inadvertently enter the food and water supply (such as aflatoxins), polychlorinated biphenyls, dioxins, metals (including mercury), persistent pesticide residues (such as DDT), and vomitoxin. This report will not focus on genetically modified foods because they involve a separate set of regulatory and biomedical issues. Caffeine or other stimulants intentionally added to food products will not be covered.

    The AAP is particularly concerned about food contact substances associated with the disruption of the endocrine system in early life, when the developmental programming of organ systems is susceptible to permanent and lifelong disruption. The international medical and scientific communities have called attention to these issues in several recent landmark reports, including a scientific statement from the Endocrine Society in 2009,51 which was updated in 2015 to account for rapidly accumulating evidence11; a joint report from the World Health Organization and United Nations Environment Programme in 201352; and a statement from the International Federation of Gynaecology and Obstetrics in 2015.53 Subsequent sections of this technical report focus on individual categories of chemicals and provide evidence on potential effects on children’s health to support the accompanying AAP policy statement.54

    Indirect Food Additives

    Bisphenols

    The use of bisphenols as food additives accelerated in the 1960s, when bisphenol A (BPA) was identified as a useful ingredient in the manufacture of polycarbonate plastics and polymeric metal can coatings.55 BPA has recently been banned from infant bottles,56 and plastic beverage containers are increasingly designated as BPA free. However, BPA and related compounds are still used in polymeric resin coatings to prevent metal corrosion in food and beverage containers.57

    BPA has been the focus of significant research and attention. It can bind to the estrogen receptor and cause tissues to respond as if estradiol is present; thus, it is classified as an “endocrine disruptor.”12 Nonhuman laboratory studies and human epidemiologic studies suggest links between BPA exposure and numerous endocrine-related end points, including reduced fertility,13,14 altered timing of puberty,15 changes in mammary gland development,16,58 and development of neoplasias.59 Environmentally relevant doses of BPA trigger the conversion of cells to adipocytes,19,60 disrupt pancreatic β-cell function in vivo,61 and affect glucose transportation in adipocytes.19–21 BPA exposure in utero has been associated with adverse neurodevelopmental outcomes,23–25 and cross-sectional studies have associated BPA with decrements in fetal growth,62 childhood obesity,63,64 and low-grade albuminuria,65 although longitudinal studies of prenatal exposure have yielded less consistent relationships with postnatal body mass.66–69

    A comprehensive, cross-sectional study of dust, indoor and outdoor air, and solid and liquid food in preschool-aged children suggested that dietary sources constitute 99% of BPA exposure.70 Dental sealants and thermal copy paper are also sources.71,72 Higher urinary concentrations of BPA have been documented in African American individuals,63 and BPA concentrations have been inversely associated with family income.73 Given that obesity is well documented to be more prevalent among low-income and minority children,74 disproportionate exposure to endocrine-disrupting chemicals, such as BPA, may partially explain sociodemographic disparities in health.75

    The FDA recently banned the use of BPA in infant bottles and sippy cups,5 and numerous companies are voluntarily removing BPA from their products because of consumer pressure. Yet, in many cases, it has been replaced with closely related alternatives, such as bisphenol S. These emerging alternatives have been identified in paper products and human urine.76,77 The few studies focused on evaluating bisphenol S have identified similar genotoxicity and estrogenicity to BPA78–82 and greater resistance to environmental degradation than BPA.83,84 Efforts to remove BPA from plastics and metal cans will only provide health and economic benefits if it is replaced with a safe alternative.55

    Phthalates

    Phthalate esters have a diverse array of uses in consumer products, and they can be classified into 2 categories: low–molecular weight phthalates are frequently added to shampoos, cosmetics, lotions, and other personal care products to preserve scent,6 whereas high–molecular weight phthalates are used to produce vinyl plastics for diverse settings ranging from flooring, clear food wrap, and flexible plastic tubing commonly used in food manufaturing.85 Within the high–molecular weight category, di-2-ethylhexylphthalate (DEHP) is of particular interest because industrial processes to produce food frequently use plastic products containing DEHP.86 Racial and/or ethnic differences in phthalate exposures are well documented.87,88

    A robust literature, including numerous animal and human studies, shows that DEHP, benzyl butyl phthalate, and dibutyl phthalate are antiandrogenic and adversely affect male fetal genital development. These chemicals exert direct testicular toxicity, thereby reducing circulating testosterone concentrations within the body and increasing the risk of hypospadias and cryptorchidism at birth. These phthalates are also associated with changes in men’s hormone concentrations and changes in sperm motility and quantity.6,27–29,89–91 Mono-(2-ethylhexyl)phthalate, a DEHP metabolite, also interacts with 3 peroxisome proliferator–activated receptors,30 which play key roles in lipid and carbohydrate metabolism, providing biological plausibility for DEHP metabolites in contributing to childhood obesity and insulin resistance.92 Epidemiologic studies have also demonstrated an association between urinary phthalate metabolites and markers of oxidative stress.33,34 Laboratory studies have found that metabolites of phthalates are linked to oxidative stress.93,94 Oxidative stress appears to diminish the insulin-dependent stimulation of insulin-signaling elements and glucose transport activity95 and modify the endothelial relaxant nitric oxide, promoting vasoconstriction, platelet adhesion, and the release of proinflammatory cytokines, such as interleukin-1.96,97 Therefore, if phthalates are proinflammatory and increase oxidative stress, these effects could lead to changes to metabolic health outcomes. Emerging animal evidence also suggests that DEHP may produce arrhythmia,35 change metabolic profiles, and produce dysfunction in cardiac myocytes.36

    Data from the National Health and Nutrition Examination Survey (NHANES) indicate that DEHP metabolites decreased by approximately 37% between 2001 and 2010.98 These decreases are attributable to the replacement of DEHP with diisodecyl (DIDP) and diisononylphthalate (DINP), phthalates that have not been banned or restricted by regulatory agencies and are increasingly detected within the population. Urinary metabolites of DIDP and DINP were detected in 94% and 98% of the population, respectively, in the 2009-2010 NHANES.98 DIDP and DINP have been widely identified as food contaminants,99 and cross-sectional data from NHANES from 2009 to 2012 show positive associations of DIDP and DINP metabolite concentrations with insulin resistance and systolic blood pressure z scores in children and adolescents.31,32

    PFCs

    PFCs are synthetic organic fluorinated compounds whose carbon–fluorine bonds impart high stability and thermal resistance. PFCs have wide utility in stain-resistant sprays for carpets and upholstery, fire-retarding foams, nonstick cooking surfaces, and grease-proofing of paper and paperboard used in food packaging.100,101 The 2003–2004 NHANES revealed that >98% of the US population has detectable concentrations of PFCs in their blood, including perfluorooctane sulfonic acid (PFOS), perfluorooctanoic acid (PFOA), perfluorohexane sulfonic acid (PFHxS), and perfluorononanoic acid (PFNA).102 Although exposure can occur through dermal contact and inhalation, consumption of contaminated food is a major route of exposure to PFOS and PFOA for most people.100 Studies have associated PFOA and PFOS exposure with adverse health outcomes, such as reduced immune response to vaccines,37,38 metabolic changes,42 and decreased birth weight.43 There is also growing concern regarding the endocrine-disrupting potential of PFCs; studies have linked PFOA and PFOS to reduced fertility39,40 and thyroid alterations41,103–105 among other effects. These compounds are also extremely persistent and bioaccumulative, with half-lives between 2 and 9 years in the human body.106

    Because of health and environmental concerns, US production of PFOS was phased out in 2002, and PFOA was phased out in 2015.107 However, these particular compounds are only 2 of more than a dozen members of the parent family. For example, closely related PFNA chiefly replaced PFOA; increasing PFNA concentrations were detected in the 2003–2004 NHANES and have remained stable thereafter.102

    In January 2016, the FDA banned the use of 3 classes of long-chain PFCs as indirect food additives.108 Yet, structurally similar short-chain PFCs, such as PFHxS, may continue to be used. Median levels of PFHxS have been measured since NHANES 2003–2004 and have remained stable through NHANES 2009–2010.109 A Swedish study of perfluoroalkyl acid trends between 1996 and 2010 confirmed increases in PFHxS concentrations (8.3% per year) but also noted increases of 11% per year in another short-chain PFC substitute for PFOS, perfluoroalkylbutane sulfonate (PFBS), which is increasingly found in food.110 Modest, infrequently (2%) detectable concentrations of PFBS were identified among the US population in NHANES 2011–2012. Although studies have not sufficiently evaluated the human health consequences of exposure to short-chain PFCs, the structural similarity to banned compounds suggests that they may also pose human health risks.111,112

    Perchlorate

    Perchlorate most commonly enters the food supply through its presence as a contaminant in water or as a component of nitrate fertilizers.44,45,113 Exposed crops may retain elevated levels of the compound, as described in exploratory studies conducted by the FDA.114 In addition, perchlorate is an indirect food additive. Contamination in food occurs through its use as an antistatic agent for plastic packaging in contact with dry foods with surfaces that do not contain free fat or oil (such as sugar, flour, and starches) or through degradation from hypochlorite bleach, which is used as a cleaning solution in food manufacturing.115

    Perchlorate is known to disrupt thyroid hormone production through interference with the sodium iodide symporter (NIS), which allows essential iodide uptake in the thyroid gland.44,116 The thyroid hormone is critical for early life brain development, among other processes, and alterations to normal hormone concentrations can have lifelong cognitive consequences.117–121 Exposure to perchlorate among pregnant women, especially those who are iodine deficient, raises particular concern given that the developing fetus is entirely reliant on the maternal thyroid hormone during the first trimester of pregnancy.117,122,123 Maternal hypothyroidism during pregnancy has been associated with cognitive deficits in children.120,121 Infants represent another important susceptible population, and the intake of powdered formula may result in high perchlorate exposure from associated packaging materials. Perchlorate and other food contaminants that alter thyroid hormone homeostasis, such as polybrominated diphenyl ethers,124–126 may be contributing to the increase in neonatal hypothyroidism and other thyroid system perturbations that have been documented in the United States.127,128 In addition, the thyroid hormone is critical for normal growth processes, and recent evidence suggests that high exposure to multiple compounds that interfere with iodide uptake is associated with poor growth outcomes.49

    Direct Food Additives

    Artificial Food Colors

    Synthetic artificial food colors (AFCs) are added to foods and beverages for aesthetic reasons, and the resulting brightly colored products are appealing to young children in particular. In some cases, AFCs serve as substitutes for nutritious ingredients, such as in fruit juice drinks that contain little or no actual fruit. Nine AFCs currently are approved for use in the United States: Blue 1, Blue 2, Green 3, Yellow 5, Yellow 6, Red 3, Red 40, Citrus Red 2, and Orange B.129 FDA data indicate that the use of AFCs increased more than fivefold between 1950 and 2012, from 12 to 68 mg per capita per day.130

    Over the last several decades, studies have raised concerns regarding the effect of AFCs on child behavior and their role in exacerbating attention-deficit/hyperactivity disorder symptoms.131–136 Elimination of AFCs from the diet may provide benefits to children with attention-deficit/hyperactivity disorder.131,137–139 Although the mechanisms of action have not yet been fully elucidated, at least one AFC, Blue 1, may cross the blood-brain barrier.135,140 Overall, however, further work is needed to better understand the implications of AFC exposure and resolve the uncertainties across the scientific evidence. The available literature should be interpreted with caution because of the absence of information about the ingredients for a number of reasons, including patent protection.

    The FDA has set acceptable daily intakes for each of the AFCs.141 However, these standards, as well as original safety approval for the color additives, are based on animal studies that do not include neurologic or neurobehavioral end points.140,142 Given that such effects have been observed in children, a thorough reassessment of AFCs is warranted to determine whether they meet the agency’s benchmark of safety: “convincing evidence that establishes with reasonable certainty that no harm will result from the intended use of the color additive.”142

    Nitrates and Nitrites

    There has been longstanding concern regarding the use of nitrates and nitrites as preservatives in cured and processed meats, fish, and cheese.143 In a 2004 statement, the American Medical Association emphasized that infants are particularly vulnerable to methemoglobinemia from nitrates and nitrites because of the chemical composition of their gastric tracts.144 The American Medical Association statement also highlighted the risk of gastrointestinal or neural cancer from the ingestion of nitrates and nitrites, which (although not carcinogenic themselves) may react with secondary amines or amides to form carcinogenic N-nitroso compounds (NOCs) in the body. In 2006, the International Agency for Research on Cancer classified ingested nitrates and nitrites, in situations that would lead to endogenous nitrosation (production of NOCs), as “probable human carcinogens” (Group 2A).10,145 In 2015, the International Agency for Research on Cancer specifically classified processed meat (which includes meat that has been salted, cured, or otherwise altered to improve flavor and preservation) as “carcinogenic to humans” (Group 1).47 Such processing can result in the increased formation of NOCs, and there is convincing evidence linking consumption of processed meats with colorectal cancer.47 High maternal intake of nitrite-cured meats has also been linked to an increased risk of childhood brain tumors in the offspring, especially tumors of the astroglia.48,145 Current FDA regulations currently allow up to 500 ppm of sodium nitrate and 200 ppm of sodium nitrite in final meat products. However, no nitrates or nitrites can be used in food produced specifically for infants or young children.146 Nitrates, like perchlorate, can also disrupt thyroid function by blocking the NIS and thereby interfering with essential iodide uptake. Although its relative potency is much lower than that of other common NIS inhibitors, nitrate is still a significant concern, given that (1) combined exposures from food and water may account for a larger proportion of NIS inhibition than from perchlorate exposure and (2) NIS inhibitors may act together additively.50,147 Thyroid hormones are essential for many physiologic processes in the body, including normal growth, and recent evidence suggests that high exposure to NIS inhibitors, including nitrate, is associated with reductions in growth measures.49 In addition, as noted above with regard to perchlorate, maternal thyroid disruption during pregnancy is of particular concern because the fetus is entirely reliant on the maternal thyroid hormone during the first trimester. Thyroid hormone is critical for neurologic developmental processes, and early life deficiencies can result in lifelong adverse effects on cognitive health.117–121

    In recent years, there has been increasing use of alternative sources of nitrate and nitrite preservatives, such as celery powder, in products labeled as “natural” and “organic.”148,149 These products may contain nitrates and nitrites in concentrations that can be equivalent to or higher than those found in traditional products using sodium-based sources.149,150 Thus, consumers should be aware that with respect to nitrates and nitrites alone, natural and organic products may not provide advantages over conventional products.

    Lead Authors

    Leonardo Trasande, MD, MPP, FAAP

    Rachel M. Shaffer, MPH

    Sheela Sathyanarayana, MD, MPH

    Council on Environmental Health Executive Committee, 2016–2017

    Jennifer A. Lowry, MD, FAAP, Chairperson

    Samantha Ahdoot, MD, FAAP

    Carl R. Baum, MD, FACMT, FAAP

    Aaron S. Bernstein, MD, MPH, FAAP

    Aparna Bole, MD, FAAP

    Carla C. Campbell, MD, MS, FAAP

    Philip J. Landrigan, MD, FAAP

    Susan E. Pacheco, MD, FAAP

    Adam J. Spanier, MD, PhD, MPH, FAAP

    Leonardo Trasande, MD, MPP, FAAP

    Alan D. Woolf, MD, MPH, FAAP

    Former Executive Committee Members

    Heather Lynn Brumberg, MD, MPH, FAAP

    Bruce P. Lanphear, MD, MPH, FAAP

    Jerome A. Paulson, MD, FAAP

    Liaisons

    John M. Balbus, MD, MPH – National Institute of Environmental Health Sciences

    Diane E. Hindman, MD, FAAP – American Academy of Pediatrics Section on Pediatric Trainees

    Nathaniel G. DeNicola, MD, MSc – American College of Obstetricians and Gynecologists

    Ruth Ann Etzel, MD, PhD, FAAP – US Environmental Protection Agency

    Mary Ellen Mortensen, MD, MS – Centers for Disease Control and Prevention and National Center for Environmental Health

    Mary H. Ward, PhD – National Cancer Institute

    Staff

    Paul Spire

    Footnotes

    • Address correspondence to Leonardo Trasande, MD, MPP, FAAP. E-mail: Leonardo.Trasande{at}nyumc.org

    • The authors are grateful to Dr. Mary Ward for her insights and comments regarding the literature on nitrates, which enhanced that section of the technical report.

    • FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.

    • FUNDING: Dr Trasande is supported by R01ES022972, R56ES027256, UG3OD023305, R01DK100307, and U01OH011299. Ms Shaffer is supported by T32ES015459. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Centers of Disease Control and Prevention.

    • POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

    • The guidance in this report does not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.

    • All technical reports from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.

    References

    1. ↵
      1. Neltner TG,
      2. Kulkarni NR,
      3. Alger HM, et al
      . Navigating the U.S. Food Additive Regulatory Program. Compr Rev Food Sci Food Saf. 2011;10(6):342–368
      OpenUrl
    2. ↵
      1. Neltner TG,
      2. Alger HM,
      3. O’Reilly JT,
      4. Krimsky S,
      5. Bero LA,
      6. Maffini MV
      . Conflicts of interest in approvals of additives to food determined to be generally recognized as safe: out of balance. JAMA Intern Med. 2013;173(22):2032–2036pmid:23925593
      OpenUrlCrossRefPubMed
    3. ↵
      1. Neltner TG,
      2. Alger HM,
      3. Leonard JE,
      4. Maffini MV
      . Data gaps in toxicity testing of chemicals allowed in food in the United States. Reprod Toxicol. 2013;42:85–94pmid:23954440
      OpenUrlCrossRefPubMed
    4. ↵
      1. Landrigan PJ,
      2. Goldman LR
      . Children’s vulnerability to toxic chemicals: a challenge and opportunity to strengthen health and environmental policy. Health Aff (Millwood). 2011;30(5):842–850pmid:21543423
      OpenUrlAbstract/FREE Full Text
    5. ↵
      1. US Food and Drug Administration
      . Update on bisphenol A for use in food contact applications: January 2010. Available at: https://www.fda.gov/downloads/NewsEvents/PublicHealthFocus/UCM197778.pdf. Accessed May 18, 2017
    6. ↵
      1. Sathyanarayana S
      . Phthalates and children’s health. Curr Probl Pediatr Adolesc Health Care. 2008;38(2):34–49pmid:18237855
      OpenUrlCrossRefPubMed
    7. ↵
      1. Forman J,
      2. Silverstein J; Committee on Nutrition; Council on Environmental Health; American Academy of Pediatrics
      . Organic foods: health and environmental advantages and disadvantages. Pediatrics. 2012;130(5): Available at: www.pediatrics.org/cgi/content/full/130/5/e1406pmid:23090335
      OpenUrlAbstract/FREE Full Text
    8. ↵
      1. Buck RC,
      2. Franklin J,
      3. Berger U, et al
      . Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integr Environ Assess Manag. 2011;7(4):513–541pmid:21793199
      OpenUrlCrossRefPubMed
    9. ↵
      1. US Food and Drug Administration
      . Filing of food additive petition. Fed Regist. 2015;80(50):13508–13510
      OpenUrl
    10. ↵
      1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
      . IARC monographs on the evaluation of carcinogenic risks to humans. Ingested nitrate and nitrite, and cyanobacterial peptide toxins. IARC Monogr Eval Carcinog Risks Hum. 2010;94:v–vii, 1–412pmid:21141240
      OpenUrlPubMed
    11. ↵
      1. Gore AC,
      2. Chappell VA,
      3. Fenton SE, et al
      . Executive summary to EDC-2: the Endocrine Society’s second scientific statement on endocrine-disrupting chemicals. Endocr Rev. 2015;36(6):593–602pmid:26414233
      OpenUrlCrossRefPubMed
    12. ↵
      1. Rubin BS
      . Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol. 2011;127(1–2):27–34pmid:21605673
      OpenUrlCrossRefPubMed
    13. ↵
      1. Ehrlich S,
      2. Williams PL,
      3. Missmer SA, et al
      . Urinary bisphenol A concentrations and early reproductive health outcomes among women undergoing IVF. Hum Reprod. 2012;27(12):3583–3592pmid:23014629
      OpenUrlCrossRefPubMed
    14. ↵
      1. Cantonwine DE,
      2. Hauser R,
      3. Meeker JD
      . Bisphenol A and human reproductive health. Expert Rev Obstet Gynecol. 2013;8(4)
    15. ↵
      1. Howdeshell KL,
      2. Hotchkiss AK,
      3. Thayer KA,
      4. Vandenbergh JG,
      5. vom Saal FS
      . Exposure to bisphenol A advances puberty. Nature. 1999;401(6755):763–764pmid:10548101
      OpenUrlCrossRefPubMed
    16. ↵
      1. Vandenberg LN,
      2. Maffini MV,
      3. Wadia PR,
      4. Sonnenschein C,
      5. Rubin BS,
      6. Soto AM
      . Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology. 2007;148(1):116–127pmid:17023525
      OpenUrlCrossRefPubMed
      1. Welshons WV,
      2. Nagel SC,
      3. vom Saal FS
      . Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology. 2006;147(6 Suppl):S56–S69pmid:16690810
      OpenUrlCrossRefPubMed
      1. Jukic AM,
      2. Calafat AM,
      3. McConnaughey DR, et al
      . Urinary concentrations of phthalate metabolites and bisphenol A and associations with follicular-phase length, luteal-phase length, fecundability, and early pregnancy loss. Environ Health Perspect. 2016;124(3):321–328pmid:26161573
      OpenUrlPubMed
    19. ↵
      1. Masuno H,
      2. Kidani T,
      3. Sekiya K, et al
      . Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res. 2002;43(5):676–684pmid:11971937
      OpenUrlAbstract/FREE Full Text
      1. Hugo ER,
      2. Brandebourg TD,
      3. Woo JG,
      4. Loftus J,
      5. Alexander JW,
      6. Ben-Jonathan N
      . Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect. 2008;116(12):1642–1647pmid:19079714
      OpenUrlCrossRefPubMed
    21. ↵
      1. Sakurai K,
      2. Kawazuma M,
      3. Adachi T, et al
      . Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol. 2004;141(2):209–214pmid:14707028
      OpenUrlCrossRefPubMed
      1. Vom Saal FS,
      2. Nagel SC,
      3. Coe BL,
      4. Angle BM,
      5. Taylor JA
      . The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol Cell Endocrinol. 2012;354(1–2):74–84pmid:22249005
      OpenUrlCrossRefPubMed
    23. ↵
      1. Braun JM,
      2. Kalkbrenner AE,
      3. Calafat AM, et al
      . Impact of early-life bisphenol A exposure on behavior and executive function in children. Pediatrics. 2011;128(5):873–882pmid:22025598
      OpenUrlAbstract/FREE Full Text
      1. Sathyanarayana S,
      2. Braun JM,
      3. Yolton K,
      4. Liddy S,
      5. Lanphear BP
      . Case report: high prenatal bisphenol A exposure and infant neonatal neurobehavior. Environ Health Perspect. 2011;119(8):1170–1175pmid:21524981
      OpenUrlCrossRefPubMed
    25. ↵
      1. Ejaredar M,
      2. Lee Y,
      3. Roberts DJ,
      4. Sauve R,
      5. Dewey D
      . Bisphenol A exposure and children’s behavior: A systematic review. J Expo Sci Environ Epidemiol. 2017;27(2):175–183pmid:26956939
      OpenUrlPubMed
      1. Mustieles V,
      2. Pérez-Lobato R,
      3. Olea N,
      4. Fernández MF
      . Bisphenol A: Human exposure and neurobehavior. Neurotoxicology. 2015;49:174–184pmid:26121921
      OpenUrlPubMed
    27. ↵
      1. Gray LE Jr,
      2. Ostby J,
      3. Furr J,
      4. Price M,
      5. Veeramachaneni DN,
      6. Parks L
      . Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol Sci. 2000;58(2):350–365pmid:11099647
      OpenUrlCrossRefPubMed
      1. Meeker JD,
      2. Ferguson KK
      . Urinary phthalate metabolites are associated with decreased serum testosterone in men, women, and children from NHANES 2011-2012. J Clin Endocrinol Metab. 2014;99(11):4346–4352pmid:25121464
      OpenUrlCrossRefPubMed
    29. ↵
      1. Swan SH,
      2. Main KM,
      3. Liu F, et al; Study for Future Families Research Team
      . Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005;113(8):1056–1061pmid:16079079
      OpenUrlCrossRefPubMed
    30. ↵
      1. Desvergne B,
      2. Feige JN,
      3. Casals-Casas C
      . PPAR-mediated activity of phthalates: a link to the obesity epidemic? Mol Cell Endocrinol. 2009;304(1–2):43–48pmid:19433246
      OpenUrlCrossRefPubMed
    31. ↵
      1. Trasande L,
      2. Attina TM
      . Association of exposure to di-2-ethylhexylphthalate replacements with increased blood pressure in children and adolescents. Hypertension. 2015;66(2):301–308pmid:26156503
      OpenUrlAbstract/FREE Full Text
    32. ↵
      1. Attina TM,
      2. Trasande L
      . Association of exposure to di-2-ethylhexylphthalate replacements with increased insulin resistance in adolescents from NHANES 2009-2012. J Clin Endocrinol Metab. 2015;100(7):2640–2650pmid:25993640
      OpenUrlPubMed
    33. ↵
      1. Ferguson KK,
      2. Loch-Caruso R,
      3. Meeker JD
      . Urinary phthalate metabolites in relation to biomarkers of inflammation and oxidative stress: NHANES 1999-2006. Environ Res. 2011;111(5):718–726pmid:21349512
      OpenUrlCrossRefPubMed
    34. ↵
      1. Ferguson KK,
      2. McElrath TF,
      3. Chen YH,
      4. Mukherjee B,
      5. Meeker JD
      . Urinary phthalate metabolites and biomarkers of oxidative stress in pregnant women: a repeated measures analysis. Environ Health Perspect. 2015;123(3):210–216
      OpenUrlPubMed
    35. ↵
      1. Posnack NG,
      2. Lee NH,
      3. Brown R,
      4. Sarvazyan N
      . Gene expression profiling of DEHP-treated cardiomyocytes reveals potential causes of phthalate arrhythmogenicity. Toxicology. 2011;279(1–3):54–64pmid:20920545
      OpenUrlPubMed
    36. ↵
      1. Posnack NG,
      2. Swift LM,
      3. Kay MW,
      4. Lee NH,
      5. Sarvazyan N
      . Phthalate exposure changes the metabolic profile of cardiac muscle cells. Environ Health Perspect. 2012;120(9):1243–1251pmid:22672789
      OpenUrlCrossRefPubMed
    37. ↵
      1. Grandjean P,
      2. Andersen EW,
      3. Budtz-Jørgensen E, et al
      . Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA. 2012;307(4):391–397pmid:22274686
      OpenUrlCrossRefPubMed
    38. ↵
      1. Granum B,
      2. Haug LS,
      3. Namork E, et al
      . Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol. 2013;10(4):373–379pmid:23350954
      OpenUrlCrossRefPubMed
    39. ↵
      1. Vélez MP,
      2. Arbuckle TE,
      3. Fraser WD
      . Maternal exposure to perfluorinated chemicals and reduced fecundity: the MIREC study. Hum Reprod. 2015;30(3):701–709pmid:25567616
      OpenUrlCrossRefPubMed
    40. ↵
      1. Fei C,
      2. McLaughlin JK,
      3. Lipworth L,
      4. Olsen J
      . Maternal levels of perfluorinated chemicals and subfecundity. Hum Reprod. 2009;24(5):1200–1205pmid:19176540
      OpenUrlCrossRefPubMed
    41. ↵
      1. Wang Y,
      2. Rogan WJ,
      3. Chen PC, et al
      . Association between maternal serum perfluoroalkyl substances during pregnancy and maternal and cord thyroid hormones: Taiwan maternal and infant cohort study. Environ Health Perspect. 2014;122(5):529–534pmid:24577800
      OpenUrlPubMed
    42. ↵
      1. Halldorsson TI,
      2. Rytter D,
      3. Haug LS, et al
      . Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study. Environ Health Perspect. 2012;120(5):668–673pmid:22306490
      OpenUrlCrossRefPubMed
    43. ↵
      1. Lam J,
      2. Koustas E,
      3. Sutton P, et al
      . The navigation guide - evidence-based medicine meets environmental health: integration of animal and human evidence for PFOA effects on fetal growth. Environ Health Perspect. 2014;122(10):1040–1051pmid:24968389
      OpenUrlPubMed
    44. ↵
      1. Centers for Disease Control and Prevention
      2. Agency for Toxic Substances and Disease Registry
      . Public health statement for perchlorates. 2008. Available at: www.atsdr.cdc.gov/phs/phs.asp?id=892&tid=181. Accessed May 18, 2017
    45. ↵
      1. Steinmaus CM
      . Perchlorate in water supplies: sources, exposures, and health effects. Curr Environ Health Rep. 2016;3(2):136–143pmid:27026358
      OpenUrlPubMed
      1. Ghassabian A,
      2. Trasande L
      . Disruption in thyroid signaling pathway: a mechanism for the effect of endocrine-disrupting chemicals on child neurodevelopment. Front Endocrinol (Lausanne). 2018;9:204
      OpenUrl
    47. ↵
      1. Bouvard V,
      2. Loomis D,
      3. Guyton KZ, et al; International Agency for Research on Cancer Monograph Working Group
      . Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015;16(16):1599–1600pmid:26514947
      OpenUrlCrossRefPubMed
    48. ↵
      1. Pogoda JM,
      2. Preston-Martin S,
      3. Howe G, et al
      . An international case-control study of maternal diet during pregnancy and childhood brain tumor risk: a histology-specific analysis by food group. Ann Epidemiol. 2009;19(3):148–160pmid:19216997
      OpenUrlCrossRefPubMed
    49. ↵
      1. Mervish NA,
      2. Pajak A,
      3. Teitelbaum SL, et al; Breast Cancer and Environment Research Project (BCERP)
      . Thyroid antagonists (perchlorate, thiocyanate, and nitrate) and childhood growth in a longitudinal study of U.S. girls. Environ Health Perspect. 2016;124(4):542–549pmid:26151950
      OpenUrlPubMed
    50. ↵
      1. Tonacchera M,
      2. Pinchera A,
      3. Dimida A, et al
      . Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid. 2004;14(12):1012–1019pmid:15650353
      OpenUrlCrossRefPubMed
    51. ↵
      1. Diamanti-Kandarakis E,
      2. Bourguignon J-P,
      3. Giudice LC, et al
      . Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009;30(4):293–342pmid:19502515
      OpenUrlCrossRefPubMed
    52. ↵
      1. Bergman Å,
      2. Heindel JJ,
      3. Jobling S,
      4. Kidd KA,
      5. Zoeller RT
      , eds. United Nations Environment Programme, World Health Organization. State of the Science of Endocrine Disrupting Chemicals – 2012. Geneva, Switzerland: WHO and UNEP; 2013, Available at www.who.int/ceh/publications/endocrine/. Accessed May 18, 2017
    53. ↵
      1. Di Renzo GC,
      2. Conry JA,
      3. Blake J, et al
      . International Federation of Gynecology and Obstetrics opinion on reproductive health impacts of exposure to toxic environmental chemicals. Int J Gynaecol Obstet. 2015;131(3):219–225pmid:26433469
      OpenUrlCrossRefPubMed
    54. ↵
      1. Trasande L,
      2. Shaffer RM,
      3. Sathyanarayana S; American Academy of Pediatrics Council on Environmental Health
      . Technical report: Food additives and child health. Pediatrics. 2018;142(2):e20181408
      OpenUrlAbstract/FREE Full Text
    55. ↵
      1. Trasande L
      . Further limiting bisphenol A in food uses could provide health and economic benefits. Health Aff (Millwood). 2014;33(2):316–323pmid:24452104
      OpenUrlAbstract/FREE Full Text
    56. ↵
      1. Tavernise S
      . F.D.A. makes it official: BPA can’t be used in baby bottles and cups. New York Times. July 17, 2012. Available at: www.nytimes.com/2012/07/18/science/fda-bans-bpa-from-baby-bottles-and-sippy-cups.html. Accessed July 18, 2012
    57. ↵
      1. Schecter A,
      2. Malik N,
      3. Haffner D, et al
      . Bisphenol A (BPA) in U.S. food. Environ Sci Technol. 2010;44(24):9425–9430pmid:21038926
      OpenUrlCrossRefPubMed
    58. ↵
      1. Muñoz-de-Toro M,
      2. Markey CM,
      3. Wadia PR, et al
      . Perinatal exposure to bisphenol-A alters peripubertal mammary gland development in mice. Endocrinology. 2005;146(9):4138–4147pmid:15919749
      OpenUrlCrossRefPubMed
    59. ↵
      1. Seachrist DD,
      2. Bonk KW,
      3. Ho SM,
      4. Prins GS,
      5. Soto AM,
      6. Keri RA
      . A review of the carcinogenic potential of bisphenol A. Reprod Toxicol. 2016;59:167–182pmid:26493093
      OpenUrlPubMed
    60. ↵
      1. Masuno H,
      2. Iwanami J,
      3. Kidani T,
      4. Sakayama K,
      5. Honda K
      . Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci. 2005;84(2):319–327
      OpenUrlCrossRefPubMed
    61. ↵
      1. Alonso-Magdalena P,
      2. Laribi O,
      3. Ropero AB, et al
      . Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environ Health Perspect. 2005;113(8):969–977pmid:16079065
      OpenUrlCrossRefPubMed
    62. ↵
      1. Snijder CA,
      2. Heederik D,
      3. Pierik FH, et al
      . Fetal growth and prenatal exposure to bisphenol A: the generation R study. Environ Health Perspect. 2013;121(3):393–398pmid:23459363
      OpenUrlPubMed
    63. ↵
      1. Trasande L,
      2. Attina TM,
      3. Blustein J
      . Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA. 2012;308(11):1113–1121pmid:22990270
      OpenUrlCrossRefPubMed
    64. ↵
      1. Wang T,
      2. Li M,
      3. Chen B, et al
      . Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab. 2012;97(2):E223–E227pmid:22090277
      OpenUrlCrossRefPubMed
    65. ↵
      1. Trasande L,
      2. Attina TM,
      3. Trachtman H
      . Bisphenol A exposure is associated with low-grade urinary albumin excretion in children of the United States. Kidney Int. 2013;83(4):741–748pmid:23302717
      OpenUrlCrossRefPubMed
    66. ↵
      1. Braun JM,
      2. Lanphear BP,
      3. Calafat AM, et al
      . Early-life bisphenol A exposure and child body mass index: a prospective cohort study. Environ Health Perspect. 2014;122(11):1239–1245pmid:25073184
      OpenUrlPubMed
      1. Valvi D,
      2. Casas M,
      3. Mendez MA, et al
      . Prenatal bisphenol A urine concentrations and early rapid growth and overweight risk in the offspring. Epidemiology. 2013;24(6):791–799pmid:24036610
      OpenUrlCrossRefPubMed
      1. Harley KG,
      2. Aguilar Schall R,
      3. Chevrier J, et al.
      Prenatal and postnatal bisphenol A exposure and body mass index in childhood in the CHAMACOS cohort. Environ Health Perspect. 2013;121(4):514–520
      OpenUrlCrossRefPubMed
    69. ↵
      1. Legler J,
      2. Fletcher T,
      3. Govarts E, et al
      . Obesity, diabetes, and associated costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015;100(4):1278–1288pmid:25742518
      OpenUrlCrossRefPubMed
    70. ↵
      1. Wilson NK,
      2. Chuang JC,
      3. Morgan MK,
      4. Lordo RA,
      5. Sheldon LS
      . An observational study of the potential exposures of preschool children to pentachlorophenol, bisphenol-A, and nonylphenol at home and daycare. Environ Res. 2007;103(1):9–20pmid:16750524
      OpenUrlPubMed
    71. ↵
      1. Fleisch AF,
      2. Sheffield PE,
      3. Chinn C,
      4. Edelstein BL,
      5. Landrigan PJ
      . Bisphenol A and related compounds in dental materials. Pediatrics. 2010;126(4):760–768pmid:20819896
      OpenUrlAbstract/FREE Full Text
    72. ↵
      1. Schwartz AW,
      2. Landrigan PJ
      . Bisphenol A in thermal paper receipts: an opportunity for evidence-based prevention. Environ Health Perspect. 2012;120(1):A14–A15, author reply A15pmid:22214814
      OpenUrlPubMed
    73. ↵
      1. Nelson JW,
      2. Scammell MK,
      3. Hatch EE,
      4. Webster TF
      . Social disparities in exposures to bisphenol A and polyfluoroalkyl chemicals: a cross-sectional study within NHANES 2003-2006. Environ Health. 2012;11:10pmid:22394520
      OpenUrlPubMed
    74. ↵
      1. Flegal KM,
      2. Carroll MD,
      3. Kit BK,
      4. Ogden CL
      . Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307(5):491–497pmid:22253363
      OpenUrlCrossRefPubMed
    75. ↵
      1. Patel CJ,
      2. Ioannidis JP,
      3. Cullen MR,
      4. Rehkopf DH
      . Systematic assessment of the correlations of household income with infectious, biochemical, physiological, and environmental factors in the United States, 1999-2006. Am J Epidemiol. 2015;181(3):171–179pmid:25589242
      OpenUrlCrossRefPubMed
    76. ↵
      1. Liao C,
      2. Liu F,
      3. Alomirah H, et al
      . Bisphenol S in urine from the United States and seven Asian countries: occurrence and human exposures. Environ Sci Technol. 2012;46(12):6860–6866pmid:22620267
      OpenUrlCrossRefPubMed
    77. ↵
      1. Liao C,
      2. Liu F,
      3. Kannan K
      . Bisphenol s, a new bisphenol analogue, in paper products and currency bills and its association with bisphenol A residues. Environ Sci Technol. 2012;46(12):6515–6522pmid:22591511
      OpenUrlCrossRefPubMed
    78. ↵
      1. Kuruto-Niwa R,
      2. Nozawa R,
      3. Miyakoshi T,
      4. Shiozawa T,
      5. Terao Y
      . Estrogenic activity of alkylphenols, bisphenol S, and their chlorinated derivatives using a GFP expression system. Environ Toxicol Pharmacol. 2005;19(1):121–130pmid:21783468
      OpenUrlCrossRefPubMed
      1. Chen MY,
      2. Ike M,
      3. Fujita M
      . Acute toxicity, mutagenicity, and estrogenicity of bisphenol-A and other bisphenols. Environ Toxicol. 2002;17(1):80–86pmid:11847978
      OpenUrlCrossRefPubMed
      1. Yoshihara S,
      2. Mizutare T,
      3. Makishima M, et al
      . Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency. Toxicol Sci. 2004;78(1):50–59pmid:14691209
      OpenUrlCrossRefPubMed
      1. Okuda K,
      2. Fukuuchi T,
      3. Takiguchi M,
      4. Yoshihara S
      . Novel pathway of metabolic activation of bisphenol A-related compounds for estrogenic activity. Drug Metab Dispos. 2011;39(9):1696–1703pmid:21636669
      OpenUrlAbstract/FREE Full Text
    82. ↵
      1. Audebert M,
      2. Dolo L,
      3. Perdu E,
      4. Cravedi JP,
      5. Zalko D
      . Use of the γH2AX assay for assessing the genotoxicity of bisphenol A and bisphenol F in human cell lines. Arch Toxicol. 2011;85(11):1463–1473pmid:21656223
      OpenUrlCrossRefPubMed
    83. ↵
      1. Danzl E,
      2. Sei K,
      3. Soda S,
      4. Ike M,
      5. Fujita M
      . Biodegradation of bisphenol A, bisphenol F and bisphenol S in seawater. Int J Environ Res Public Health. 2009;6(4):1472–1484pmid:19440529
      OpenUrlCrossRefPubMed
    84. ↵
      1. Ike M,
      2. Chen MY,
      3. Danzl E,
      4. Sei K,
      5. Fujita M
      . Biodegradation of a variety of bisphenols under aerobic and anaerobic conditions. Water Sci Technol. 2006;53(6):153–159pmid:16749452
      OpenUrlAbstract/FREE Full Text
    85. ↵
      1. Schettler T
      . Human exposure to phthalates via consumer products. Int J Androl. 2006;29(1):134–139, discussion 181–185pmid:16466533
      OpenUrlCrossRefPubMed
    86. ↵
      1. Fromme H,
      2. Gruber L,
      3. Schlummer M, et al
      . Intake of phthalates and di(2-ethylhexyl)adipate: results of the Integrated Exposure Assessment Survey based on duplicate diet samples and biomonitoring data. Environ Int. 2007;33(8):1012–1020pmid:17610953
      OpenUrlCrossRefPubMed
    87. ↵
      1. Wolff MS,
      2. Teitelbaum SL,
      3. Windham G, et al
      . Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls. Environ Health Perspect. 2007;115(1):116–121pmid:17366830
      OpenUrlPubMed
    88. ↵
      1. Silva MJ,
      2. Barr DB,
      3. Reidy JA, et al
      . Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect. 2004;112(3):331–338pmid:14998749
      OpenUrlPubMed
    89. ↵
      1. Gray LE Jr,
      2. Wilson VS,
      3. Stoker T, et al
      . Adverse effects of environmental antiandrogens and androgens on reproductive development in mammals. Int J Androl. 2006;29(1):96–104, discussion 105–108pmid:16466529
      OpenUrlCrossRefPubMed
      1. Hauser R,
      2. Meeker JD,
      3. Singh NP, et al
      . DNA damage in human sperm is related to urinary levels of phthalate monoester and oxidative metabolites. Hum Reprod. 2007;22(3):688–695pmid:17090632
      OpenUrlCrossRefPubMed
    91. ↵
      1. Hauser R,
      2. Skakkebaek NE,
      3. Hass U, et al
      . Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015;100(4):1267–1277pmid:25742517
      OpenUrlCrossRefPubMed
    92. ↵
      1. Trasande L,
      2. Attina TM,
      3. Sathyanarayana S,
      4. Spanier AJ,
      5. Blustein J
      . Race/ethnicity-specific associations of urinary phthalates with childhood body mass in a nationally representative sample. Environ Health Perspect. 2018;121(4):501
      OpenUrl
    93. ↵
      1. Jepsen KF,
      2. Abildtrup A,
      3. Larsen ST
      . Monophthalates promote IL-6 and IL-8 production in the human epithelial cell line A549. Toxicol In Vitro. 2004;18(3):265–269pmid:15046772
      OpenUrlCrossRefPubMed
    94. ↵
      1. Seo KW,
      2. Kim KB,
      3. Kim YJ,
      4. Choi JY,
      5. Lee KT,
      6. Choi KS
      . Comparison of oxidative stress and changes of xenobiotic metabolizing enzymes induced by phthalates in rats. Food Chem Toxicol. 2004;42(1):107–114
      OpenUrlCrossRefPubMed
    95. ↵
      1. Henriksen EJ,
      2. Diamond-Stanic MK,
      3. Marchionne EM
      . Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med. 2011;51(5):993–999pmid:21163347
      OpenUrlCrossRefPubMed
    96. ↵
      1. Singh U,
      2. Jialal I
      . Oxidative stress and atherosclerosis. Pathophysiology. 2006;13(3):129–142pmid:16757157
      OpenUrlCrossRefPubMed
    97. ↵
      1. Harrison D,
      2. Griendling KK,
      3. Landmesser U,
      4. Hornig B,
      5. Drexler H
      . Role of oxidative stress in atherosclerosis. Am J Cardiol. 2003;91(3A):7A–11Apmid:12645638
      OpenUrlCrossRefPubMed
    98. ↵
      1. Zota AR,
      2. Calafat AM,
      3. Woodruff TJ
      . Temporal trends in phthalate exposures: findings from the National Health and Nutrition Examination Survey, 2001-2010. Environ Health Perspect. 2014;122(3):235–241pmid:24425099
      OpenUrlCrossRefPubMed
    99. ↵
      1. Serrano SE,
      2. Braun J,
      3. Trasande L,
      4. Dills R,
      5. Sathyanarayana S
      . Phthalates and diet: a review of the food monitoring and epidemiology data. Environ Health. 2014;13(1):43pmid:24894065
      OpenUrlPubMed
    100. ↵
      1. Trudel D,
      2. Horowitz L,
      3. Wormuth M,
      4. Scheringer M,
      5. Cousins IT,
      6. Hungerbühler K
      . Estimating consumer exposure to PFOS and PFOA. Risk Anal. 2008;28(2):251–269pmid:18419647
      OpenUrlCrossRefPubMed
    101. ↵
      1. Centers for Disease Control and Prevention
      2. Agency for Toxic Substances and Disease Registry
      . Public health statement: perfluoroalkyls. 2009. Available at: www.atsdr.cdc.gov/toxprofiles/tp200-c1-b.pdf. Accessed May 18, 2017
    102. ↵
      1. Calafat AM,
      2. Wong LY,
      3. Kuklenyik Z,
      4. Reidy JA,
      5. Needham LL
      . Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect. 2007;115(11):1596–1602pmid:18007991
      OpenUrlCrossRefPubMed
    103. ↵
      1. Wen L-L,
      2. Lin L-Y,
      3. Su T-C,
      4. Chen P-C,
      5. Lin C-Y
      . Association between serum perfluorinated chemicals and thyroid function in U.S. adults: the National Health and Nutrition Examination Survey 2007-2010. J Clin Endocrinol Metab. 2013;98(9):E1456–E1464pmid:23864701
      OpenUrlCrossRefPubMed
      1. C8 Science Panel
      . Probable link evaluation of thyroid disease. July 20, 2012. Available at: www.c8sciencepanel.org/pdfs/Probable_Link_C8_Thyroid_30Jul2012.pdf. Accessed May 18, 2017
    105. ↵
      1. Melzer D,
      2. Rice N,
      3. Depledge MH,
      4. Henley WE,
      5. Galloway TS
      . Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ Health Perspect. 2010;118(5):686–692pmid:20089479
      OpenUrlCrossRefPubMed
    106. ↵
      1. US Environmental Protection Agency
      . Emerging contaminants - perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA). 2014
    107. ↵
      1. US Environmental Protection Agency
      . Long-chain perfluorinated chemicals (PFCs) action plan. 2009. Available at: https://www.epa.gov/sites/production/files/2016-01/documents/pfcs_action_plan1230_09.pdf. Accessed May 18, 2017
    108. ↵
      1. US Food and Drug Administration
      . Indirect food additives: paper and paperboard components. 2016. Available at: https://www.federalregister.gov/documents/2016/01/04/2015-33026/indirect-food-additives-paper-and-paperboard-components. Accessed May 18, 2017
    109. ↵
      1. Calafat AM,
      2. Wong LY,
      3. Kuklenyik Z,
      4. Reidy JA,
      5. Needham LL
      . Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect. 2007;115(11):1596–1602
      OpenUrlCrossRefPubMed
    110. ↵
      1. Glynn A,
      2. Berger U,
      3. Bignert A, et al
      . Perfluorinated alkyl acids in blood serum from primiparous women in Sweden: serial sampling during pregnancy and nursing, and temporal trends 1996-2010. Environ Sci Technol. 2012;46(16):9071–9079pmid:22770559
      OpenUrlCrossRefPubMed
    111. ↵
      1. Scheringer M,
      2. Trier X,
      3. Cousins IT, et al
      . Helsingør statement on poly- and perfluorinated alkyl substances (PFASs). Chemosphere. 2014;114:337–339pmid:24938172
      OpenUrlPubMed
    112. ↵
      1. Blum A,
      2. Balan SA,
      3. Scheringer M, et al
      . The Madrid statement on poly-and perfluoroalkyl substances (PFASs). Environ Health Perspect. 2015;123(5):A107–A111pmid:25932614
      OpenUrlPubMed
    113. ↵
      1. European Commission
      . Food contaminants. 2015. Available at: http://ec.europa.eu/food/food/chemicalsafety/contaminants/index_en.htm. Accessed May 18, 2017
    114. ↵
      1. US Food and Drug Administration
      . Preliminary estimation of perchlorate dietary exposure based on FDA 2004/2005 exploratory data. Available at: www.fda.gov/Food/FoodborneIllnessContaminants/ChemicalContaminants/ucm077653.htm. Accessed May 18, 2017
    115. ↵
      1. Maffini MV,
      2. Trasande L,
      3. Neltner TG
      . Perchlorate and diet: human exposures, risks, and mitigation strategies. Curr Environ Health Rep. 2016;3(2):107–117pmid:27029550
      OpenUrlPubMed
    116. ↵
      1. Rogan WJ,
      2. Paulson JA,
      3. Baum C, et al; Council on Environmental Health
      . Iodine deficiency, pollutant chemicals, and the thyroid: new information on an old problem. Pediatrics. 2014;133(6):1163–1166pmid:24864180
      OpenUrlAbstract/FREE Full Text
    117. ↵
      1. Zoeller RT,
      2. Rovet J
      . Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol. 2004;16(10):809–818pmid:15500540
      OpenUrlCrossRefPubMed
      1. Miller MD,
      2. Crofton KM,
      3. Rice DC,
      4. Zoeller RT
      . Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environ Health Perspect. 2009;117(7):1033–1041pmid:19654909
      OpenUrlCrossRefPubMed
      1. Moog NK,
      2. Entringer S,
      3. Heim C,
      4. Wadhwa PD,
      5. Kathmann N,
      6. Buss C
      . Influence of maternal thyroid hormones during gestation on fetal brain development. Neuroscience. 2017;342:68–100pmid:26434624
      OpenUrlCrossRefPubMed
    120. ↵
      1. Päkkilä F,
      2. Männistö T,
      3. Hartikainen AL, et al
      . Maternal and child’s thyroid function and child’s intellect and scholastic performance. Thyroid. 2015;25(12):1363–1374pmid:26438036
      OpenUrlCrossRefPubMed
    121. ↵
      1. Haddow JE,
      2. Palomaki GE,
      3. Allan WC, et al
      . Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999;341(8):549–555pmid:10451459
      OpenUrlCrossRefPubMed
    122. ↵
      1. US Environmental Protection Agency
      2. Science Advisory Board
      . Perchlorate - Approaches for Deriving Maximum Contaminant Level Goals for Drinking Water. 2013. Available at: https://yosemite.epa.gov/sab/sabproduct.nsf/02ad90b136fc21ef85256eba00436459/d3bb75d4297ca4698525794300522ace!OpenDocument&TableRow=2.2. Accessed May 18, 2017
    123. ↵
      1. Steinmaus C,
      2. Pearl M,
      3. Kharrazi M, et al
      . Thyroid hormones and moderate exposure to perchlorate during pregnancy in women in southern California. Environ Health Perspect. 2016;124(6):861–867pmid:26485730
      OpenUrlPubMed
    124. ↵
      1. Abdelouahab N,
      2. Langlois MF,
      3. Lavoie L,
      4. Corbin F,
      5. Pasquier JC,
      6. Takser L
      . Maternal and cord-blood thyroid hormone levels and exposure to polybrominated diphenyl ethers and polychlorinated biphenyls during early pregnancy. Am J Epidemiol. 2013;178(5):701–713
      OpenUrlCrossRefPubMed
      1. Schecter A,
      2. Päpke O,
      3. Harris TR, et al
      . Polybrominated diphenyl ether (PBDE) levels in an expanded market basket survey of U.S. food and estimated PBDE dietary intake by age and sex. Environ Health Perspect. 2006;114(10):1515–1520pmid:17035135
      OpenUrlPubMed
    126. ↵
      1. Wu N,
      2. Herrmann T,
      3. Paepke O, et al
      . Human exposure to PBDEs: associations of PBDE body burdens with food consumption and house dust concentrations. Environ Sci Technol. 2007;41(5):1584–1589pmid:17396645
      OpenUrlPubMed
    127. ↵
      1. Hinton CF,
      2. Harris KB,
      3. Borgfeld L, et al
      . Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas. Pediatrics. 2010;125(suppl 2):S37–S47pmid:20435716
      OpenUrlAbstract/FREE Full Text
    128. ↵
      1. Cao Y,
      2. Blount BC,
      3. Valentin-Blasini L,
      4. Bernbaum JC,
      5. Phillips TM,
      6. Rogan WJ
      . Goitrogenic anions, thyroid-stimulating hormone, and thyroid hormone in infants. Environ Health Perspect. 2010;118(9):1332–1337pmid:20439182
      OpenUrlCrossRefPubMed
    129. ↵
      1. US Food and Drug Administration
      . Summary of color additives for use in the United States in foods, drugs, cosmetics, and medical devices. Available at: www.fda.gov/ForIndustry/ColorAdditives/ColorAdditiveInventories/ucm115641.htm. Accessed May 18, 2017
    130. ↵
      1. Stevens LJ,
      2. Burgess JR,
      3. Stochelski MA,
      4. Kuczek T
      . Amounts of artificial food colors in commonly consumed beverages and potential behavioral implications for consumption in children. Clin Pediatr (Phila). 2014;53(2):133–140pmid:24037921
      OpenUrlCrossRefPubMed
    131. ↵
      1. Nigg JT,
      2. Lewis K,
      3. Edinger T,
      4. Falk M
      . Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. J Am Acad Child Adolesc Psychiatry. 2012;51(1):86–97.e8pmid:22176942
      OpenUrlCrossRefPubMed
      1. Stevens LJ,
      2. Kuczek T,
      3. Burgess JR,
      4. Stochelski MA,
      5. Arnold LE,
      6. Galland L
      . Mechanisms of behavioral, atopic, and other reactions to artificial food colors in children. Nutr Rev. 2013;71(5):268–281pmid:23590704
      OpenUrlCrossRefPubMed
      1. Millichap JG,
      2. Yee MM
      . The diet factor in attention-deficit/hyperactivity disorder. Pediatrics. 2012;129(2):330–337pmid:22232312
      OpenUrlAbstract/FREE Full Text
      1. Weiss B
      . Synthetic food colors and neurobehavioral hazards: the view from environmental health research. Environ Health Perspect. 2012;120(1):1–5pmid:21926033
      OpenUrlPubMed
    135. ↵
      1. Arnold LE,
      2. Lofthouse N,
      3. Hurt E
      . Artificial food colors and attention-deficit/hyperactivity symptoms: conclusions to dye for. Neurotherapeutics. 2012;9(3):599–609
      OpenUrlCrossRefPubMed
    136. ↵
      1. Kleinman RE,
      2. Brown RT,
      3. Cutter GR,
      4. Dupaul GJ,
      5. Clydesdale FM
      . A research model for investigating the effects of artificial food colorings on children with ADHD. Pediatrics. 2011;127(6):e1575–e1584pmid:21576306
      OpenUrlAbstract/FREE Full Text
    137. ↵
      1. Nigg JT,
      2. Holton K
      . Restriction and elimination diets in ADHD treatment. Child Adolesc Psychiatr Clin N Am. 2014;23(4):937–953pmid:25220094
      OpenUrlCrossRefPubMed
      1. Arnold LE,
      2. Hurt E,
      3. Lofthouse N
      . Attention-deficit/hyperactivity disorder: dietary and nutritional treatments. Child Adolesc Psychiatr Clin N Am. 2013;22(3):381–402, vpmid:23806311
      OpenUrlPubMed
    139. ↵
      1. Stevenson J,
      2. Buitelaar J,
      3. Cortese S, et al
      . Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder--an appraisal of the evidence on efficacy and recommendations on the design of future studies. J Child Psychol Psychiatry. 2014;55(5):416–427pmid:24552603
      OpenUrlCrossRefPubMed
    140. ↵
      1. US Food and Drug Administration
      . Food advisory committee meeting. March 30-31, 2011. Available at: https://wayback.archive-it.org/org-1137/20170406211705/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/FoodAdvisoryCommittee/UCM255119.pdf. Accessed May 18, 2017
    141. ↵
      1. US Food and Drug Administration
      2. Background Document for the Food Advisory Committee
      . Certified color additives in food and possible association with attention deficit hyperactivity disorder in children. March 30–31, 2011. Available at: https://wayback.archive-it.org/org-1137/20170406211659/https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/FoodAdvisoryCommittee/UCM248549.pdf. Accessed May 18, 2017
    142. ↵
      Food and drugs color additives. Fed Regist. 1977; Codified as 21 CFR 70
    143. ↵
      1. Tricker AR,
      2. Preussmann R
      . Carcinogenic N-nitrosamines in the diet: occurrence, formation, mechanisms and carcinogenic potential. Mutat Res. 1991;259(3–4):277–289pmid:2017213
      OpenUrlCrossRefPubMed
    144. ↵
      1. American Medical Association
      2. Council on Scientific Affairs
      . Labeling of Nitrite Content of Processed Foods. Chicago, IL: American Medical Association; 2004
    145. ↵
      1. Grosse Y,
      2. Baan R,
      3. Straif K,
      4. Secretan B,
      5. El Ghissassi F,
      6. Cogliano V; WHO International Agency for Research on Cancer Monograph Working Group
      . Carcinogenicity of nitrate, nitrite, and cyanobacterial peptide toxins. Lancet Oncol. 2006;7(8):628–629pmid:16900606
    146. ↵
      Food additives permitted for direct addition to food for human consumption - food preservatives - sodium nitrite. Fed Regist. 2005; Codified as 21 CFR 1721.175
    147. ↵
      1. De Groef B,
      2. Decallonne BR,
      3. Van der Geyten S,
      4. Darras VM,
      5. Bouillon R
      . Perchlorate versus other environmental sodium/iodide symporter inhibitors: potential thyroid-related health effects. Eur J Endocrinol. 2006;155(1):17–25pmid:16793945
    148. ↵
      1. Sebranek JG,
      2. Jackson-Davis AL,
      3. Myers KL,
      4. Lavieri NA
      . Beyond celery and starter culture: advances in natural/organic curing processes in the United States. Meat Sci. 2012;92(3):267–273pmid:22445489
      OpenUrlAbstract/FREE Full Text
    149. ↵
      1. Neuman W
      . What’s inside the bun? New York Times. July 1, 2011. Available at www.nytimes.com/2011/07/02/business/02hotdog.html. Accessed May 18, 2017
    150. ↵
      1. Nuñez De González MT,
      2. Osburn WN,
      3. Hardin MD, et al
      . Survey of residual nitrite and nitrate in conventional and organic/natural/uncured/indirectly cured meats available at retail in the United States. J Agric Food Chem. 2012;60(15):3981–3990pmid:22414374
      OpenUrlPubMed
    Back to top

    In this issue

    Pediatrics
    Vol. 142, Issue 2
    1 Aug 2018
    View this article with LENS
    Email Article
    Request Permissions
    Article Alerts
    Citation Tools
    Food Additives and Child Health
    Leonardo Trasande, Rachel M. Shaffer, Sheela Sathyanarayana, COUNCIL ON ENVIRONMENTAL HEALTH
    Pediatrics Aug 2018, 142 (2) e20181410; DOI: 10.1542/peds.2018-1410
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Print
    Download PDF
    Insight Alerts

    Jump to section

    Subjects